+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cellulite Treatment Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5786933

The global cellulite treatment market size attained a value of nearly USD 1.75 billion in 2022. The market is anticipated to grow at a CAGR of 10.86% during the forecast period of 2023-2031 to reach a value of USD 4.44 billion by 2031. The growth of the market can be attributed to the high demand for cosmetic procedures and the presence of advanced healthcare infrastructure.



Cellulite Treatment Market: Introduction

Cellulite is a term used to describe the dimpled, lumpy appearance of the skin, especially on the thighs, hips, buttocks, and abdomen. It is caused by the accumulation of subcutaneous fat beneath the skin, which pushes against connective tissue, causing the skin to pucker and dimple. Cellulite is more common in women than men, and it is not considered a medical condition. It is generally considered a cosmetic concern, and there are various treatments available to reduce its appearance.

The cellulite treatment market refers to the range of products and services available to reduce or eliminate the appearance of cellulite on the skin. As cellulite is a common cosmetic concern, the market for cellulite treatment has grown significantly in recent years, with a wide range of options available to consumers.

These treatments can range from topical creams and lotions to invasive procedures such as liposuction. Other treatments include non-invasive procedures such as laser therapy, radiofrequency treatments, and acoustic wave therapy. These treatments aim to reduce the appearance of cellulite by either breaking down the underlying fat or smoothing out the skin's surface. The market for cellulite treatment is driven by the increasing demand for cosmetic procedures and the growing awareness of body image issues. The availability of a wide range of treatment options and advancements in technology has also contributed to the growth of the market.

However, the effectiveness of these treatments varies, and some may be expensive or have potential side effects. Therefore, it is essential to consult a medical professional before considering any cellulite treatment.

Cellulie - Epidemiology

Cellulite is a very common cosmetic concern, particularly among women. However, as it is not a medical condition, there is no formal epidemiological data available on its prevalence or incidence. According to some estimates, it is believed that over 85% of women over the age of 21 have some degree of cellulite on their bodies. The condition is less common in men, affecting only about 10% of the male population.

Cellulite is more prevalent in older individuals, as the skin loses elasticity, and the subcutaneous fat accumulates with age. It is also more common in those who are overweight or obese. However, it can affect individuals of any weight, and even those who lead healthy lifestyles. Cellulite is more likely to appear on specific areas of the body, including the thighs, hips, buttocks, and abdomen. It can also develop on the arms and calves, although this is less common.

While cellulite is not a medical condition, its prevalence and impact on body image have led to a significant market for cellulite treatments, including topical creams, non-invasive procedures, and surgical interventions.

Cellulite Treatment Market Segmentations

Market Breakup by Treatment Type

  • Energy-Based Treatment
  • Mechanical Suction and Thermal
  • Radiofrequency
  • Ultrasound
  • Cry lipolysis
  • Mechanical Suction
  • Others
  • Non-Energy Based Treatment

Market Breakup by Procedure Type

  • Non-invasive
  • Minimally invasive
  • Topical

Market Breakup by Cellulite Type

  • Soft Cellulite
  • Hard Cellulite
  • Oedematous Cellulite

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Others

Cellulite Treatment Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Cellulite Treatment Market Scenario

North America dominates the global cellulite treatment market due to the high demand for cosmetic procedures and the presence of advanced healthcare infrastructure. However, the market is expected to grow significantly in the Asia Pacific region due to the increasing disposable income and growing awareness of body image issues.

The cellulite treatment market has witnessed significant developments in recent years, with a growing focus on the development of non-invasive and minimally invasive treatments.

One of the key developments in the market is the use of laser therapy for cellulite treatment. Laser treatments use a high-energy beam of light to target and break down fat cells, leading to smoother and firmer skin. These treatments are less invasive than traditional liposuction and have shown promising results in reducing the appearance of cellulite.

Another major development is the use of radiofrequency (RF) treatments for cellulite reduction. RF treatments use electromagnetic waves to heat up the underlying tissue, which stimulates collagen production and improves skin texture. These treatments are minimally invasive and require little to no downtime.

Other key developments include the use of acoustic wave therapy, which uses sound waves to break down fat cells, and the development of topical creams and lotions that contain ingredients such as caffeine and retinol, which are believed to improve the appearance of cellulite.

In addition to these developments, there has been a growing trend towards combination treatments, which involve using multiple techniques to achieve optimal results. For example, some clinics may offer a combination of laser therapy, RF treatments, and topical creams to reduce the appearance of cellulite.

Overall, the cellulite treatment market is expected to continue to grow as new technologies and treatments are developed and as the demand for cosmetic procedures continues to increase.

Key Players in the Global Cellulite Treatment Market

The report gives an in-depth analysis of the key players involved in the cellulite treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

  • Cutera
  • Nestle
  • Merz Pharmaceuticals, LLC
  • Inceler Medikal Co Ltd
  • Shanghai Fosun Pharmaceutical Group Co. Ltd
  • Hologic Inc
  • Candela Corporation
  • Mentor Worldwide LLC
  • Zimmer Aesthetics
  • Tanceuticals
  • Nubway Co. Ltd
  • Allergan


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Cellulite Diseases Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
4.4 Global Contraceptive Drugs Product Landscape
5 Cellulite Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Cellulite Epidemiology (2016-2031)
5.3 Europe Cellulite Epidemiology (2016-2031)
5.4 Asia-Pacific Cellulite Epidemiology (2016-2031)
5.5 Latin America Cellulite Epidemiology (2016-2031)
5.6 Middle East & Africa Cellulite Epidemiology (2016-2031)
6 Global Cellulite Treatment Market Overview
6.1 Global Cellulite Treatment Market Historical Value (2016-2022)
6.2 Global Cellulite Treatment Market Forecast Value (2023-2031)
7 Global Cellulite Treatment Market Landscape
7.1 Cellulite Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Cellulite Treatment: Product Landscape
7.2.1 Analysis by Treatment Type
7.2.2 Analysis by Procedure Type
7.2.3 Analysis by Cellulite Type
7.2.4 Analysis by End User
8 Cellulite Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Cellulite Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Cellulite Treatment Market Segmentation
11.1 Global Cellulite Treatment Market by Treatment Type
11.1.1 Market Overview
11.1.2 Energy-Based Treatment
11.1.2.1 Mechanical Suction and Thermal
11.1.2.2 Radiofrequency
11.1.2.3 Ultrasound
11.1.2.4 Cry lipolysis
11.1.2.5 Mechanical Suction
11.1.2.6 Others
11.1.3 Non-Energy Based Treatment
11.2 Global Cellulite Treatment Market by Procedure Type
11.2.1 Market Overview
11.2.2 Non-invasive
11.2.3 Minimally Invasive
11.2.4 Topical
11.3 Global Cellulite Treatment Market by Cellulite Type
11.3.1 Market Overview
11.3.2 Soft Cellulite
11.3.3 Hard Cellulite
11.3.4 Edematous Cellulite
11.4 Global Cellulite Treatment Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Specialty Clinics
11.4.4 Ambulatory Surgical Centers
11.4.5 Others
11.5 Global Cellulite Treatment Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Cellulite Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Cellulite Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Cellulite Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Cellulite Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Cellulite Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Cutera
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Nestle
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Merz Pharmaceuticals, LLC
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Inceler Medikal Co Ltd.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Shanghai Fosun Pharmaceutical Group Co. Ltd.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Hologic Inc.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Candela Corporation
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Mentor Worldwide LLC
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Zimmer Aesthetics
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Tanceuticals
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Nubway Co. Ltd.
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Allergan
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
24 Cellulite Treatment Market- Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket

Companies Mentioned

  • Cynosure, Inc.
  • Cutera, Inc.
  • Nestlé S.A.
  • Merz, Inc.
  • Mentor Worldwide LLC
  • Fosun Pharmaceutical Co. Ltd.
  • Allergan plc
  • Syneron Medical Ltd.
  • Others

Methodology

Loading
LOADING...

Table Information